| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.5 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |